Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness of Standard Versus Pathogen-reduced Buffy Coat-derived Platelet Concentrates in Plasma in Hemato-oncological Patients.

NCT02783313 is registered in ClinicalTrials.gov with Sanquin Research & Blood Bank Divisions as lead sponsor.

NCT NCT02783313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness of Standard Versus Pathogen-reduced Buffy Coat-derived Platelet Concentrates in Plasma in Hemato-oncological Patients.
Lead sponsor
Sanquin Research & Blood Bank Divisions
Phase
Not applicable
Overall status
Completed
Start date
November 17, 2010
Completion date
June 30, 2016
Enrollment
567 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia